Sucden Ventures
VC Fund
Sucden Ventures is a VC fund focused on Biotechnology and Food and Beverage. Sucden Ventures, the CVC arm of Sucden
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Sucden Ventures invests in
Stages Sucden Ventures invests in
Countries Sucden Ventures invests in
Round sizes
Round size
- Series B
- $18M–$38M
- Series C
- $35M–$105M
Investment Focus
Industry
- Biotechnology 3 (43%)
- Food and Beverage 3 (43%)
- Chemical 1 (14%)
- Nutrition 1 (14%)
- E-Commerce 1 (14%)
Stage
- Series B 2 (29%)
- Seed 1 (14%)
- Series C 1 (14%)
- Funding Round 1 (14%)
- Venture - Series Unknown 1 (14%)
Country
- Israel 2 (29%)
- United States 2 (29%)
- United Kingdom 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. | $105M / Series C / Mar 12, 2026 | |
|
|
Joywell Foods is developing the first healthy, protein sweeteners. Derived from exotic plants, protein sweeteners are rare compounds that provide an amazing taste without the calories. These proteins, produced through fermentation, have no glycemic impact and do not affect the gut microbiome. The company has received regulatory approvals, includingFDA "no questions" letters and GRAS status for multiple proteins | $18M / Series B / Feb 13, 2025 | |
|
|
Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $38M / Series B / Sep 17, 2024 | |
|
|
Blue Tree’s mission is to develop a sugar reduction platform for industrial applications in the drinks industry. | $2.3M / Seed / Jul 30, 2024 | |
|
|
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. | $35M / Series C / Jul 06, 2022 | |
|
|
Amai Proteins ('Amai' is 'sweet' in Japanese) is transforming the food and beverage industry by presenting healthy and tasty protein ingredients for everyday use. The Designer Protein Company first focus is Sweet Designer Proteins as sugar substitutes. Amai is taking sweet proteins found in the equatorial belt and is applyingAgile Integrative Computational Protein Design (AI-CPD) and fermentation to make the proteins fit for the mass food market. | $5.3M / Jul 01, 2021 | |
|
|
Amai Proteins ('Amai' is 'sweet' in Japanese) is transforming the food and beverage industry by presenting healthy and tasty protein ingredients for everyday use. The Designer Protein Company first focus is Sweet Designer Proteins as sugar substitutes. Amai is taking sweet proteins found in the equatorial belt and is applyingAgile Integrative Computational Protein Design (AI-CPD) and fermentation to make the proteins fit for the mass food market. | $5.3M / Venture - Series Unknown / Jul 01, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sucden Ventures invest in?
Sucden Ventures invests primarily in Biotechnology, Food and Beverage and Chemical startups, most often at Series B and Seed stage. Most of the 7 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sucden Ventures's check size?
Sucden Ventures typically joins rounds of $18M–$38M at Series B and $35M–$105M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sucden Ventures participates in.
When did Sucden Ventures last invest?
The most recent investment recorded for Sucden Ventures closed in Mar 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!